Genetic variants in association studies review of strengths and weaknesses in study design and current knowledge of impact on cancer risk

Acta Oncologica

Volumn 48, Issue 7, 2009, Pages 948-954

  Andersson, Ulrika ^a   McKean Cowdin, Roberta ^b   Hjalmars, Ulf ^a   Malmer, Beatrice ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN TUMOR; CANCER RISK; CHILDHOOD CANCER; CHROMOSOME 8Q; DISEASE ASSOCIATION; FALSE POSITIVE RESULT; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; PRIORITY JOURNAL; REVIEW; SAMPLE SIZE; SINGLE NUCLEOTIDE POLYMORPHISM;

GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; NEOPLASMS; PHARMACOGENETICS; PHENOTYPE; POLYMORPHISM, GENETIC; PREDICTIVE VALUE OF TESTS; RARE DISEASES; RESEARCH DESIGN; RISK ASSESSMENT; SAMPLE SIZE;

EID: 70350047277     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860903124648     Document Type: Review

References (39)

1. Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, Gibbs RA, et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007;/449:/851-61.
2. Frazer KA, Murray SS, Schork NJ, Topol EJ. Human genetic variation and its contribution to complex traits. Nat Rev Genet 2009;/10:/241-51.
3. Saxena R, Voight BF, Lyssenko V, Burtt Np, de Bakker PI, Chen H, et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007;/ 316:/1331-6.
4. Frayling TM, Timpson NJ,Weedon MN, Zeggini E, Freathy RM, Lindgren CM, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007;/316:/889-94.
5. Pearson TA, Manolio TA. How to interpret a genome-wide association study. JAMA 2008;/299:/1335-44.
6. Garcia-Closas M, Chanock S. Genetic susceptibility loci for breast cancer by estrogen receptor status. Clin Cancer Res 2008;/14:/8000-9.
7. Garcia-Closas M, Hall P, Nevanlinna H, Pooley K, Morrison J, Richesson DA, et al. Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet 2008;/4:/e1000054.
8. Houlston RS, Webb E, Broderick P, Pittman AM, Di Bernardo MC, Lubbe S, et al. Meta-analysis of genomewide association data identifies four new susceptibility loci for colorectal cancer. Nat Genet 2008;/40:/1426-35.
9. Eeles RA, Kote-Jarai Z, Giles GG, Olama AA, Guy M, Jugurnauth SK, et al. Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet 2008;/ 40:/316-21.
10. Easton DF, Eeles RA. Genome-wide association studies in cancer. Hum Mol Genet 2008;/17:/R109-15.
11. Kiemeney LA, Thorlacius S, Sulem P, Geller F, Aben KK, Stacey SN, et al. Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat Genet 2008;/ 40:/1307-12.
12. Rafnar T, Sulem P, Stacey SN, Geller F, Gudmundsson J, Sigurdsson A, et al. Sequence variants at the TERTCLPTM1L locus associate with many cancer types. Nat Genet 2009;/41:/221-7.
13. Gudmundsson J, Sulem P, Gudbjartsson DF, Jonasson JG, Sigurdsson A, Bergthorsson JT, et al. Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat Genet 2009;/41:/460-4.
14. Ioannidis JP, Bernstein J, Boffetta P, Danesh J, Dolan S, Hartge P, et al. A network of investigator networks in human genome epidemiology. Am J Epidemiol 2005;/162:/302-4.
15. Ioannidis JP, Gwinn M, Little J, Higgins JP, Bernstein JL, Boffetta P, et al. A road map for efficient and reliable human genome epidemiology. Nat Genet 2006;/38:/3-5.
16. Seminara D, Khoury MJ, O'Brien TR, Manolio T, Gwinn ML, Little J, et al. The emergence of networks in human genome epidemiology: Challenges and opportunities. Epidemiology 2007;/18:/1-8.
17. Rothman N, Skibola CF, Wang SS, Morgan G, Lan O, Smith MT, et al. Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: A report from the Inter- Lymph Consortium. Lancet Oncol 2006;/7:/27-38.
18. Little J, Higgins JP, Ioannidis JP, Moher D, Gagnon F, Von Elm E, et al. STrengthening the REporting of Genetic Association studies (STREGA)-an extension of the STROBE statement. Eur J Clin Invest 2009;/39:/247-66.
19. Di Bernardo MC, Crowther-Swanepoel D, Broderick P, Webb E, Sellick G, Wild R, et al. A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia. Nat Genet 2008;/40:/1204-10.
20. Gail MH, Pfeiffer RM, Wheeler W, Pee D. Probability that a two-stage genome-wide association study will detect a disease-associated snp and implications for multistage designs. Ann Hum Genet 2008;/72:/812-20.
21. Chanock SJ, Manolio T, Boehnke M, Boerwinkle E, Hunder DJ, Thomas G, et al. Replicating genotype-phenotype associations. Nature 2007;/447:/655-60.
22. Hemminki K, Li X, Vaittinen P, Dong C. Cancers in the first-degree relatives of children with brain tumours. Br J Cancer 2000;/83:/407-11.
23. Searles Nielsen S, Mueller BA, Preston-Martin S, Holly EA, Little J, Bracci PM, et al. Family cancer history and risk of brain tumors in children: Results of the SEARCH international brain tumor study. Cancer Causes Control 2008;/19:/ 641-648
24. Narod SA, Stiller C, Lenoir GM. An estimate of the heritable fraction of childhood cancer. Br J Cancer 1991;/ 63:/993-9.
25. Searles Nielsen S, Mueller BA, De Roos AJ, Viernes HM, Farin FM, Checkoway H. Risk of brain tumors in children and susceptibility to organophosphorus insecticides: The potential role of paraoxonase (PON1). Environ Health Perspect 2005;/113:/909-13.
26. Searles Nielsen S, Mueller BA, De Roos AJ, Checkoway H. Newborn screening archives as a specimen source for epidemiologic studies: Feasibility and potential for bias. Ann Epidemiol 2008;/18:/58-64.
27. Tiwari HK, Barnholtz-Sloan J, Wineinger N, Padilla MA, Vaughan LK, Allison DB. Review and evaluation of methods correcting for population stratification with a focus on underlying statistical principles. Hum Hered 2008;/66:/ 67-86.
28. Salmela E, Lappalainen T, Fransson I, Andersen PM, Dahlman-Wright K, Fiebig A, et al. Genome-wide analysis of single nucleotide polymorphisms uncovers population structure in Northern Europe. PLoS ONE 2008;/3:/e3519.
29. Wang J, Shete S. A test for genetic association that incorporates information about deviation from Hardy- Weinberg proportions in cases. Am J Hum Genet 2008;/83:/ 53-63.
30. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false: An approach for molecular epidemiology studies. J Natl Cancer Inst 2004;/96:/434-42.
31. Bethke L, Murray A, Webb E, Shoemaker M, Muir K, McKinney, et al. Comprehensive analysis of DNA repair gene variants and risk of meningioma. J Natl Cancer Inst 2008;100:270-276
32. Ghoussaini M, Song H, Koessler T, Al Olama AA, Kote- Jarai Z, Driver KE, et al. Multiple loci with different cancer specificities within the 8q24 gene desert. J Natl Cancer Inst 2008;/100:/962-6.
33. Yeager M, Xiao N, Hayes RB, Bouffard O, Desany B, Burdett L, et al. Comprehensive resequence analysis of a 136 kb region of human chromosome 8q24 associated with prostate and colon cancers. Hum Genet 2008;/124:/161-70.
34. Wang Y, Broderick P, Webb E, Wu X, Vijayakrishnan J, Matakidou A, et al. Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat Genet 2008;/40:/1407-9.
35. Gail MH. Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk. J Natl Cancer Inst 2008;/100:/1037-41.
36. Pepe MS, Feng Z, Janes H, Bossuyt PM, Potter JD. Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: Standards for study design. J Natl Cancer Inst 2008;/100:/1432-8.
37. Zheng SL, Sun J, Wiklund F, Smith S, Stattin P, Li G, et al. Cumulative association of five genetic variants with prostate cancer. N Engl J Med 2008;/358:/910-9.
38. Salinas CA, Koopmeiners JS, Kwon EM, Fitzgerald L, Lin DW, Ostrander EA, et al. Clinical utility of five genetic variants for predicting prostate cancer risk and mortality. Prostate 2009;/69:/363-72.
39. Zheng SL, Sun J, Wiklund F, Gao Z, Stattin P, Purcell LD, et al. Genetic variants and family history predict prostate cancer similar to prostate-specific antigen. Clin Cancer Res 2009;/15:/1105-11.